QuickView for Tex267 (gene)

1. Lung cancer A549 cells with ILF2 shRNA knockdown
2. Multiple myeloma NCI-H929 cells with ILF2 shRNA knockdown
3. Plasma cell leukemia JJN-3 cells expressing ILF2 shRNA and treated with melphalan
4. The Cancer Genome Atlas (TCGA) - somatic mutations in stomach adenocarcinoma
5. AP20187 treatment in wildtype and Atf4 KO mice expressing Fv2E-Perk transgene

1. NF45 inhibits cardiomyocyte apoptosis following myocardial ischemia-reperfusion injury.
2. Deletion of interleukin enhancer binding factor 2 (ILF2) resulted in defective biliary development a…
3. Nuclear factor 45 of tongue sole (Cynoglossus semilaevis): evidence for functional differentiation b…
4. Interleukin-2 enhancer binding factor 2 (ILF2) in pacific white shrimp (Litopenaeus vannamei): Alter…
5. NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development.

There were no clinical trials for Tex267